Abstract
Chemical investigation of a peanut-associated fungal strain Aspergillus niger IMBC-NMTP01 resulted in isolation and identification of 14 secondary metabolites, including two new, epi-aspergillusol (1) and aspernigin (3), and 12 known compounds: pyrophen (2), 2-(hydroxyimino)-3-(4-hydroxyphenyl)propanoic acid (4), aspergillusol A (5), rubrofusarin B (6), nigerasperone A (7), fonsecin (8), TMC-256C1 (9), pyranonigrin A (10), orlandin (11), nigerasperone C (12), asperpyrone A (13), and 5-(hydroxymethyl)-2-furancarboxylic acid (14). Compounds 9, 12-14 showed cytotoxicity toward all six human cancer cell lines, including HepG2, KB, HL-60, MCF-7, SK-Mel2, and LNCaP, with IC50 values ranging from 8.4 to 84.5 µM, compounds 3-5 were cytotoxic against five cancer cell lines except HepG2, whereas 1 exhibited cytotoxicity toward HepG2, KB, and MCF-7 cells. All of the compounds, except 2 and 13, inhibited NO overproduction in LPS-induced RAW264.7 cells. In addition, all of the compounds displayed antimicrobial effects against Enterococcus faecalis, whereas 13 compounds, except 10, significantly inhibited the growth of the yeast Candida albicans.
![](/cms/asset/bce926a2-fa90-4021-8902-18c4a66daf78/gnpl_a_1868462_uf0001_c.jpg)
Acknowledgements
The authors are thankful to the Institute of Chemistry, VAST for measurement of the NMR spectra; Prof. Do Thi Thao, Institute of Biotechnology, VAST for the cytotoxicity and NO inhibitory assays; Dr. Vu Thi Quyen, Institute of Marine Biochemistry, VAST for antimicrobial assay; and Dr. Bui Huu Tai, Institute of Marine Biochemistry, VAST for measurement of the HRESITOFMS and ECD spectra.
Disclosure statement
No potential conflict of interest was reported by the authors.